• contact us navContact Us
  • search navSearch
Let's connect

Want to discuss your project or have any questions?

Inflammation and immunology

Comprehensive immunological profiling 

Inflammation is a major driver in numerous diseases, from infections to autoimmune disorders and cancer. At Nuvisan, our state-of-the-art in vitro and in vivo/ex vivo model systems, including advanced co-cultures, offer precise and tailored solutions to thoroughly assess inflammation and immunology-related queries. Our cutting-edge approach helps expedite the identification and development of innovative therapies. 

Inflammatory signalling is dependent on a plethora of distinct immune cell subsets

Our immunology platform 

By  integrating data from advanced tools and technologies, such as spectral flow cytometry, cytokine profiling, (humanised) mouse models and customised functional assays, our immunology platform offers a profound understanding of immune responses at both cellular and molecular levels. These capabilities are essential for identifying novel targets and biomarkers, enhancing diagnostics and evaluating therapeutic responses. 

LEARN MORE

Immunology and inflammation in vivo models 

We offer a comprehensive range of inflammatory and autoimmune in vivo models, covering diseases affecting the human body, including joints, skin, lungs, liver and peritoneum. We provide various application routes for your drug candidate and offer flexible study designs tailored to your specific needs. Our high-quality assessments include in vivo efficacy, relevant biomarkers, histopathology and pharmacokinetic (PK) evaluations. Our team of experienced Nuvisan scientists specialises in inflammation and autoimmune disease models, helping ensure the success of your drug discovery program. 

 
LEARN MORE

Our immuno-oncology in vivo models  

By partnering with us, you gain access to a comprehensive portfolio of customised services to accelerate your immuno-oncology project. Leveraging our extensive industry experience, we provide expert advice and conduct the most appropriate studies to advance your immuno-oncology program from exploratory stages through to the preclinical and clinical phases. 

LEARN MORE

Unlock disease insights with our human iPSC platform 

Take advantage of our iPSC models to explore human disease pathogenesis and progression. We provide models for drug efficacy testing, with a particular focus on cardiology and neurology. To evaluate neuronal inflammation and cellular crosstalk, we also offer iPSC-derived microglia. Our scientists are available to discuss additional indications and customise solutions to meet your specific needs. 

LEARN MORE
 
v.1.1.1203